Cambridge, Massachusetts-based Vaxess develops a shelf-stable vaccine patch with the potential for self-application.
The company’s MiMix system features sustained-release technology for administering vaccines and therapeutics. For vaccines, its controlled release simulates the pace of a natural infection. The company said this helps the body produce a slow, strong and enduring immune response ramp.
Get the full story at our sister site, Drug Delivery Business News.
Bende previously served as global head of new products at Sanofi Pasteur. He led international, multifunctional teams at the pharmaceutical giant. That included assessing the commercial viability of potential new products.
Prior to Sanofi, Bende held the role of senior policy advisor for the HHS National Vaccine Program Office. Before that, his roles included president and CEO of Bacilligen, consultant for Science & Policy Strategies and The Livingston Group. He also served as VP of scientific affairs for Generic Pharmaceutical Association and as a researcher and administrator at NIAID.
Get the full story at our sister site, Drug Delivery Business News.